Literature DB >> 10483683

[Plantain (Plantago lanceolata L.): anti-inflammatory action in upper respiratory tract infections].

T Wegener1, K Kraft.   

Abstract

Plantain (Plantago lanceolata L.) is used for the therapy of infections of the upper respiratory airways. While only few clinical data are available, results of experimental research confirm e.g. antiinflammatory, spasmolytic and immunostimulatory actions. A positive benefit-risk-ratio allows the recommendation of plantain in moderate chronic irritative cough, also especially for children.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10483683

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  5 in total

Review 1.  COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?

Authors:  Dâmaris Silveira; Jose Maria Prieto-Garcia; Fabio Boylan; Omar Estrada; Yris Maria Fonseca-Bazzo; Claudia Masrouah Jamal; Pérola Oliveira Magalhães; Edson Oliveira Pereira; Michal Tomczyk; Michael Heinrich
Journal:  Front Pharmacol       Date:  2020-09-23       Impact factor: 5.810

2.  Stability Study and a 14-Day Oral Dose Toxicity in Rats of Plantain Leaf Extract (Plantago lanceolata L.) Syrup.

Authors:  Kenza Mansoor; Fadi Qadan; Mathias Schmidt; Eyad Mallah; Wael Abudayyih; Khalid Matalka
Journal:  Sci Pharm       Date:  2017-03-22

3.  Efficacy and safety of the syrup "KalobaTUSS®" as a treatment for cough in children: a randomized, double blind, placebo-controlled clinical trial.

Authors:  Ilaria Carnevali; Rita La Paglia; Lara Pauletto; Floriana Raso; Marco Testa; Carmen Mannucci; Emanuela Elisa Sorbara; Gioacchino Calapai
Journal:  BMC Pediatr       Date:  2021-01-11       Impact factor: 2.125

4.  Efficacy and tolerability of a polysaccharide-resin-honey based cough syrup as compared to carbocysteine syrup for children with colds: a randomized, single-blinded, multicenter study.

Authors:  Herman Avner Cohen; Moshe Hoshen; Shmuel Gur; Arie Bahir; Yoseph Laks; Hannah Blau
Journal:  World J Pediatr       Date:  2016-07-15       Impact factor: 9.186

5.  Efficacy of Grintuss® pediatric syrup in treating cough in children: a randomized, multicenter, double blind, placebo-controlled clinical trial.

Authors:  Mario Canciani; Vitalia Murgia; Davide Caimmi; Sreedhar Anapurapu; Amelia Licari; Gian Luigi Marseglia
Journal:  Ital J Pediatr       Date:  2014-06-10       Impact factor: 2.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.